Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Three compounds from Dadap leaves may help treat hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib may help treat severe hair loss, but more research is needed.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.